Skip to content

Efficacy of pethidine, Diclofenac suppository and combination of them on duration of hospitalization of renal colic patients

Comparison of the efficacy and safety of pethidine, Diclofenac suppository and combination of them on duration of hospitalization of renal colic patients in Imam Reza Hospital Kermanshah 1389

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201012145389N1
Enrollment
90
Registered
2011-03-24
Start date
2010-12-26
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic. Calculus of urinary tract in diseases classified elsewhere

Interventions

Intervention 1: Pethidine, 50 mg IV injection, on arrival and 30 minutes later. Intervention 2: Diclofenac, 50 mg Suppository, on arrival and 30 minutes later. Intervention 3: Pethidine, 50 mg IV inje
Treatment - Drugs
Pethidine, 50 mg IV injection, on arrival and 30 minutes later
Diclofenac, 50 mg Suppository, on arrival and 30 minutes later
Pethidine, 50 mg IV injection as well as Diclofenac, 50 mg Suppository, on arrival and 30 minutes later

Sponsors

Kermanshah University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: clinical diagnosis of acute renal colic (colic Flank pain may be associated with urinary symptoms including urinary frequency, dysuria, or hamaturia. Other causes of flank pain should be ruled out by P/E or ultrasound), age 18 to 60 years, pain intensity more than 5 according to VAS Exclusion criteria: Pregnancy, breast feeding, analgesic consumption in six hours prior to the intervention, presence of renal failure, warfarin consumption, contraindication of NSAIDs or opioids consumption, presence of bleeding tendency, drug addiction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: befoer and 30 minutes after the intervention. Method of measurement: vas scale.;Hospital stay. Timepoint: At discharge from hospital. Method of measurement: Registration records.

Secondary

MeasureTime frame
Hypertension. Timepoint: 15,30, and 40 minutes after the intervention. Method of measurement: sphygmomanometer.;Nausea. Timepoint: 15,30, and 40 minutes after the intervention. Method of measurement: Asking from the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ali Taherinia

Kermanshah University of Medical Sciences and Health Services

dr_alitaheri@yahoo.com+98 83 1427 6299

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026